2',3'-dideoxycytidine 5'-triphosphate has been researched along with bekanamycin in 1 studies
Studies (2',3'-dideoxycytidine 5'-triphosphate) | Trials (2',3'-dideoxycytidine 5'-triphosphate) | Recent Studies (post-2010) (2',3'-dideoxycytidine 5'-triphosphate) | Studies (bekanamycin) | Trials (bekanamycin) | Recent Studies (post-2010) (bekanamycin) |
---|---|---|---|---|---|
5 | 0 | 2 | 118 | 4 | 39 |
Protein | Taxonomy | 2',3'-dideoxycytidine 5'-triphosphate (IC50) | bekanamycin (IC50) |
---|---|---|---|
3-oxoacyl-[acyl-carrier-protein] synthase 3 | Escherichia coli | 6.3 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hu, Y; Li, QS; Li, ZL; Zhang, HJ; Zhu, DD; Zhu, HL | 1 |
1 other study(ies) available for 2',3'-dideoxycytidine 5'-triphosphate and bekanamycin
Article | Year |
---|---|
Design, synthesis and biological evaluation of urea derivatives from o-hydroxybenzylamines and phenylisocyanate as potential FabH inhibitors.
Topics: 3-Oxoacyl-(Acyl-Carrier-Protein) Synthase; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Drug Design; Enzyme Inhibitors; Escherichia coli; Escherichia coli Infections; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Models, Molecular; Protein Binding; Urea | 2011 |